183 related articles for article (PubMed ID: 11717805)
1. AIDSVAX. VaxGen.
Billich A
Curr Opin Investig Drugs; 2001 Sep; 2(9):1203-8. PubMed ID: 11717805
[TBL] [Abstract][Full Text] [Related]
2. AIDSVAX VaxGen.
Billich A
Curr Opin Investig Drugs; 2004 Feb; 5(2):214-21. PubMed ID: 15043397
[TBL] [Abstract][Full Text] [Related]
3. HIV gp120 vaccine - VaxGen: AIDSVAX, AIDSVAX B/B, AIDSVAX B/E, HIV gp120 vaccine - Genentech, HIV gp120 vaccine AIDSVAX - VaxGen, HIV vaccine AIDSVAX - VaxGen.
Adis International Ltd
Drugs R D; 2003; 4(4):249-53. PubMed ID: 12848591
[TBL] [Abstract][Full Text] [Related]
4. First human efficacy trial of AIDS vaccine in developing country.
CVI Newswatch; 1999 May; (1):2. PubMed ID: 12295316
[TBL] [Abstract][Full Text] [Related]
5. Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3.
Francis DP; Gregory T; McElrath MJ; Belshe RB; Gorse GJ; Migasena S; Kitayaporn D; Pitisuttitham P; Matthews T; Schwartz DH; Berman PW
AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S325-31. PubMed ID: 9814961
[TBL] [Abstract][Full Text] [Related]
6. Future paths for HIV vaccine research: Exploiting results from recent clinical trials and current scientific advances.
Bansal GP; Malaspina A; Flores J
Curr Opin Mol Ther; 2010 Feb; 12(1):39-46. PubMed ID: 20140815
[TBL] [Abstract][Full Text] [Related]
7. Let's go for human testing of vaccine, says UNAIDS.
UN Chron; 1999; 36(1):23. PubMed ID: 12295240
[TBL] [Abstract][Full Text] [Related]
8. Large HIV vaccine trial begins.
Santiago L
GMHC Treat Issues; 1998 Oct; 12(10):1-5. PubMed ID: 11365900
[TBL] [Abstract][Full Text] [Related]
9. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.
Pitisuttithum P; Gilbert P; Gurwith M; Heyward W; Martin M; van Griensven F; Hu D; Tappero JW; Choopanya K;
J Infect Dis; 2006 Dec; 194(12):1661-71. PubMed ID: 17109337
[TBL] [Abstract][Full Text] [Related]
10. Vaccines.
AIDS Policy Law; 1999 Aug; 14(14):12. PubMed ID: 11367001
[TBL] [Abstract][Full Text] [Related]
11. Remune. Immune Response.
Lai D; Jones T
Curr Opin Investig Drugs; 2002 Mar; 3(3):391-8. PubMed ID: 12054085
[TBL] [Abstract][Full Text] [Related]
12. AIDSVAX is safe, but efficacy question remains. VaxGen founder discusses quest for AIDS vaccine.
Francis DP
AIDS Alert; 2001 Nov; 16(11):141-2, 147. PubMed ID: 11692665
[No Abstract] [Full Text] [Related]
13. Controversial HIV vaccine enters phase III trials amid skepticism.
AIDS Alert; 1998 Dec; 13(12):133-4, 136. PubMed ID: 11366059
[TBL] [Abstract][Full Text] [Related]
14. HIV vaccine research in Thailand: lessons learned.
Pitisuttithum P
Expert Rev Vaccines; 2008 Apr; 7(3):311-7. PubMed ID: 18393601
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic vaccine trails in Thailand.
Churdboonchart V
J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562
[TBL] [Abstract][Full Text] [Related]
16. Funding support lacking in search for HIV vaccine.
AIDS Alert; 1999 Jan; 14(1):5-7. PubMed ID: 11366091
[TBL] [Abstract][Full Text] [Related]
17. First large-scale U.S. trial of HIV vaccine begins soon.
AIDS Policy Law; 1998 Jun; 13(12):10. PubMed ID: 11365517
[TBL] [Abstract][Full Text] [Related]
18. National vaccine effort seen as insufficient.
AIDS Alert; 1998 Jan; 13(1):4-6. PubMed ID: 11364864
[TBL] [Abstract][Full Text] [Related]
19. An HIV vaccine: how and when?
Esparza J
Bull World Health Organ; 2001; 79(12):1133-7. PubMed ID: 11799445
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of attitude, risk behavior and expectations among Thai participants in Phase I/II HIV/AIDS vaccine trials.
Maek-A-Nantawat W; Pitisuttithum P; Phonrat B; Bussaratid V; Naksrisook S; Peonim W; Thantamnu N; Muanaum R
J Med Assoc Thai; 2003 Apr; 86(4):299-307. PubMed ID: 12757073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
